|
WDR3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.937500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.523190E-03 |
| Normal-vs-Stage2 |
1.853570E-01 |
| Normal-vs-Stage3 |
9.724200E-01 |
| Normal-vs-Stage4 |
3.997200E-01 |
| Stage1-vs-Stage2 |
6.909400E-01 |
| Stage1-vs-Stage3 |
7.980200E-02 |
| Stage1-vs-Stage4 |
3.014400E-02 |
| Stage2-vs-Stage3 |
3.658000E-01 |
| Stage2-vs-Stage4 |
1.134180E-01 |
| Stage3-vs-Stage4 |
4.407800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.641900E-02 |
| Normal-vs-AfricanAmerican |
9.597000E-03 |
| Normal-vs-Asian |
8.102400E-01 |
| Caucasian-vs-AfricanAmerican |
4.648200E-01 |
| Caucasian-vs-Asian |
3.129800E-01 |
| AfricanAmerican-vs-Asian |
4.643400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.54250000000378E-05 |
| Normal-vs-Female |
2.711800E-01 |
| Male-vs-Female |
9.83549999999944E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.289790E-01 |
| Normal-vs-Extreme_Weight |
1.756040E-04 |
| Normal-vs-Obese |
2.520000E-01 |
| Normal-vs-Extreme_Obese |
8.993800E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.558980E-01 |
| Normal_Weight-vs-Obese |
7.653400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.059800E-01 |
| Extreme_Weight-vs-Obese |
8.314000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.197200E-01 |
| Obese-vs-Extreme_Obese |
4.543400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.919190E-01 |
| Normal-vs-Age(41-60Yrs) |
3.312400E-02 |
| Normal-vs-Age(61-80Yrs) |
2.864300E-03 |
| Normal-vs-Age(81-100Yrs) |
4.377000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.942400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.436100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.860200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.708200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.389760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.286600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.08219999999759E-05 |
| Normal-VS-Type2 PRCC |
1.930960E-01 |
| Normal-VS-KIRP CIMP |
1.611760E-02 |
| Normal-VS-Unclassified PRCC |
4.553200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.076300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.475700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.733800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.030900E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
7.173000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.379200E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.153500E-04 |
| Normal-vs-N1 |
1.506400E-01 |
| Normal-vs-N2 |
6.103400E-01 |
| N0-vs-N1 |
3.881900E-03 |
| N0-vs-N2 |
3.475000E-01 |
| N1-vs-N2 |
8.954200E-01 |
|
|
